Related Experiment Video
Updated: Mar 22, 2026

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
Published on: April 7, 2017
The role of the HGF/Met axis in mesothelioma
Thivyan Thayaparan1, James F Spicer2, John Maher3
1King's College London, King's Health Partners Integrated Cancer Centre, Department of Research Oncology, Guy's Hospital Campus, Great Maze Pond, London SE1 9RT, U.K. Thivyan.t.thayaparan@kcl.ac.uk.
Abstract:
Malignant mesothelioma is an asbestos-related cancer that occurs most commonly in the pleural space and is incurable. Increasing evidence suggests that aberrant receptor tyrosine kinase (RTK)-directed signalling plays a key role in the pathogenesis of this cancer. In the majority of mesotheliomas, up-regulated expression or signalling by Met, the receptor for hepatocyte growth factor (HGF) can be demonstrated. Following binding of ligand, Met relays signals that promote cell survival, proliferation, movement, invasiveness, branching morphogenesis and angiogenesis. Here we describe the HGF/Met axis and review the mechanisms that lead to the aberrant activation of this signalling system in mesothelioma. We also describe the cross-talk that occurs between HGF/Met and a number of other receptors, ligands and co-receptor systems. The prevalent occurrence of HGF/Met dysregulation in patients with mesothelioma sets the scene for the investigation of pharmaceutical inhibitors of this axis. In light of the inter-relationship between HGF/Met and other ligand receptor, combinatorial targeting strategies may provide opportunities for therapeutic advancement in this challenging tumour.
Insights
Malignant mesothelioma, an incurable asbestos-related cancer, involves aberrant signaling of receptor tyrosine kinases (RTKs). The hepatocyte growth factor (HGF)/Met pathway is frequently dysregulated, offering therapeutic targets.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Malignant mesothelioma is an incurable asbestos-related cancer primarily affecting the pleural space.
- Receptor tyrosine kinase (RTK)-directed signaling is increasingly implicated in mesothelioma pathogenesis.
- Aberrant signaling of the Met receptor tyrosine kinase, activated by hepatocyte growth factor (HGF), is common in mesothelioma.
Purpose of the Study:
- To describe the HGF/Met signaling axis.
- To review mechanisms of aberrant HGF/Met activation in mesothelioma.
- To explore therapeutic strategies targeting the HGF/Met pathway and its interactions.
Main Methods:
- Review of existing literature on HGF/Met signaling in mesothelioma.
- Analysis of mechanisms leading to aberrant HGF/Met activation.
- Examination of cross-talk between HGF/Met and other signaling pathways.
Main Results:
- The HGF/Met axis promotes cell survival, proliferation, movement, invasiveness, and angiogenesis.
- Dysregulation of the HGF/Met pathway is prevalent in mesothelioma.
- Significant cross-talk exists between HGF/Met and other receptor/ligand systems.
Conclusions:
- Aberrant HGF/Met signaling is a key driver in malignant mesothelioma.
- Targeting the HGF/Met axis presents a promising therapeutic avenue.
- Combinatorial strategies targeting HGF/Met and related pathways may advance treatment for mesothelioma.
Related Concept Videos
Mitogens and the Cell Cycle
Regulation of Angiogenesis and Blood Supply
TGF - β Signaling Pathway
Hedgehog Signaling Pathway
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Abnormal Proliferation

